Suzhou Medsys Tech Co Ltd Asset Resilience Ratio
Suzhou Medsys Tech Co Ltd asset resilience ratio. Suzhou Medsys Tech Co Ltd (603990) has an Asset Resilience Ratio of 11.52% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 603990 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Suzhou Medsys Tech Co Ltd (2017–2024)
Asset resilience ratio of Suzhou Medsys Tech Co Ltd from 2017 to 2024. This chart shows how Suzhou Medsys Tech Co Ltd's Asset Resilience Ratio has changed over time. Read Suzhou Medsys Tech Co Ltd debt and liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Suzhou Medsys Tech Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Suzhou Medsys Tech Co Ltd (603990) total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥140.00 Million | 11.52% |
| Total Liquid Assets | CN¥140.00 Million | 11.52% |
Asset Resilience Insights
- Moderate Liquidity: Suzhou Medsys Tech Co Ltd has 11.52% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
Suzhou Medsys Tech Co Ltd Industry Peers by Asset Resilience Ratio
Compare Suzhou Medsys Tech Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Longmaster Information Tech
SHE:300288 |
Health Information Services | 0.68% |
|
Painchek Ltd
AU:PCK |
Health Information Services | 55.69% |
|
Medadvisor Ltd
AU:MDR |
Health Information Services | 12.37% |
|
Trivarx Ltd
AU:TRI |
Health Information Services | 2.55% |
|
Intelicare Holdings Ltd
AU:ICR |
Health Information Services | 64.05% |
|
Pro Medicus Ltd
AU:PME |
Health Information Services | 17.07% |
|
ARTRYA Ltd
AU:AYA |
Health Information Services | 32.70% |
|
Cogstate Ltd
AU:CGS |
Health Information Services | 54.90% |
Suzhou Medsys Tech Co Ltd Asset Resilience Ratio by Year (2017–2024)
Suzhou Medsys Tech Co Ltd asset resilience ratio by year from 2017 to 2024. The table below shows the annual Asset Resilience Ratio data for Suzhou Medsys Tech Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 1.27% | CN¥40.10 Million ≈ $5.87 Million |
CN¥3.16 Billion ≈ $463.00 Million |
-2.82pp |
| 2023-12-31 | 4.09% | CN¥160.06 Million ≈ $23.42 Million |
CN¥3.92 Billion ≈ $572.93 Million |
-1.31pp |
| 2022-12-31 | 5.40% | CN¥88.07 Million ≈ $12.89 Million |
CN¥1.63 Billion ≈ $238.58 Million |
-19.07pp |
| 2021-12-31 | 24.47% | CN¥321.14 Million ≈ $46.99 Million |
CN¥1.31 Billion ≈ $192.04 Million |
+24.80pp |
| 2020-12-31 | -0.33% | CN¥-5.00 Million ≈ $-731.67K |
CN¥1.52 Billion ≈ $222.67 Million |
+0.43pp |
| 2019-12-31 | -0.76% | CN¥-5.80 Million ≈ $-848.99K |
CN¥760.27 Million ≈ $111.25 Million |
-15.13pp |
| 2017-12-31 | 14.37% | CN¥90.00 Million ≈ $13.17 Million |
CN¥626.50 Million ≈ $91.68 Million |
-- |
About Suzhou Medsys Tech Co Ltd
Suzhou MedicalSystem Technology Co., Ltd. provides solutions in clinical informatics and digital hospital field in China. It offers DoCare anesthesia clinical information system that focuses on serving the perioperative clinical work; and provides streamlined, informational, automatic, and intelligent integrated management platform for clinical business. The company also provides DoCare intensive… Read more